Adaptive Biotechnologies Corp

NASDAQ:ADPT  
46.89
+1.06 (+2.31%)
Other Pre-Announcement

Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results

Published: 11/10/2020 21:50 GMT
Adaptive Biotechnologies Corp (ADPT) - Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results.
Q3 Revenue $26.3 Million Versus Refinitiv Ibes Estimate of $23.6 Million.
Not Providing 2020 Financial Guidance Due to Continued Uncertainties From Impact of Covid-19.
Qtrly Net Loss per Share Attributable to Common Shareholders $0.27.